NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)

Value: £36.1m
Closes: 30 Nov 2026 (22 days)
Where: Yorkshire and the Humber
Lots: 1
Suitable for SMEs: Yes, says the buyer
Contract: 1 May 2027 – 31 Dec 2028

Framework: winning a place puts you on an approved list for future work. It's the entry ticket, not guaranteed work.

In plain English

Leeds Teaching Hospitals NHS Trust, for the North East and Yorkshire NHS Pharmaceutical Purchasing Consortium, is setting up a list of approved suppliers of unlicensed imported medicines for NHS and other public sector bodies, running from 1 May 2027 to 31 December 2028. A place on the framework is the entry ticket to future work, not guaranteed work, and the estimated value is £36,095,687.

Good fit for: MHRA-licensed pharmaceutical wholesalers and importers who already supply unlicensed medicines to the NHS.

The catch (with the notice's own words):

Needs MHRA import and supply licences Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK
Must show GMP and GDP compliance demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards

Written with AI from the official notice. Check the notice before relying on it.

What the buyer says

The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a framework agreement for the supply of Unlicensed Imported Medicines on behalf of NHS organisations and other eligible public sector bodies. The framework will provide access to a defined range of unlicensed imported medicines, including products requiring over-labelling and translation. These medicines do not hold a UK Marketing Authorisation but are licensed in their country of origin and may be imported and supplied in accordance with Regulation 167 of the Human Medicines Regulations 2012 where a patient's clinical needs cannot be met by a suitable licensed alternative. Suppliers will be required to hold all relevant MHRA licences, authorisations and approvals necessary to import, distribute and supply unlicensed medicines within the UK, and to demonstrate compliance with applicable Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards. The framework will provide participating organisations with access to safe, compliant and quality-assured products through a robust and competitive procurement arrangement. Products and suppliers will be subject to comprehensive quality, risk and commercial assessment to support regulatory compliance, supply chain resilience, continuity of patient care and value for money across the NHS.

Read the official notice Tender documents

Getting the documents

atamis-1928.my.site.com/s/Welcome (the buyer's own site, usually free to register).

Procedure: Competitive flexible procedure (Flexible: the buyer sets the stages, often a shortlist first, then bids). Published 13 Oct 2026.

Similar open tenders

Dental Implants, Digital Services & Associated Products · NHS Greater Glasgow and Clyde · closes 11 Nov
Dental Equipment, Consumables & Solutions · Supply Chain Coordination Limited · closes 11 Nov
NP93827 Seasonal Influenza Vaccine · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · closes 12 Nov
Oesophageal Radiofrequency Ablation Device and Consumables · Business Services Organisation Procurement and Logistics Service · closes 12 Nov
Uniforms, Workwear, PPE, Clothing and Associated Services · Kent County Council (t/a Procurement Services) · closes 12 Nov

Want tenders like this, matched to your firm?

Winnable emails the few new tenders that fit you each weekday, with the catch spelled out. £29/month after a 14-day free trial (no card needed).

Start free trial